BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, February 12, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 4, 2006
View Archived Issues
Anthrax antibody therapeutic Anthim completes phase I study
Read More
GSK and Pharmacopeia establish drug discovery and development alliance
Read More
Phase III study of CellCept in pemphigus vulgaris completes enrollment
Read More
CFD Therapeutics formed to advance novel cancer therapeutics
Read More
Pro-Pharmaceuticals advances phase II colorectal cancer trial of Davanat plus 5-FU
Read More
New series of KDR inhibitors presented by Amgen
Read More
Activity of pertuzumab evaluated in advanced ovarian cancer
Read More
Studies add to data on stem cell mobilization with AMD-3100
Read More
Phase I/II trial finds lenalidomide promising in recurrent epithelial ovarian cancer
Read More
Actavis reaffirms proposal to acquire Pliva
Read More
MediciNova begins phase I study for urinary incontinence treatment MN-246
Read More
Ispinesib fails to meet advancement criteria in platinum-sensitive NSCLC
Read More
Proteon Therapeutics raises funding to support development of PRT-201
Read More
NitroMed restructures R&D operations
Read More
Astellas changes Protopic label in Europe
Read More
Toyama and Astellas sign basic licensing agreement for T-3811 in Japan
Read More
Santen and Oakwood sign agreement on microsphere-based product for DME
Read More
Alfresa and Tanabe Seiyaku to comarket modafinil in Japan
Read More
Novel PAI-1 inhibitor from Wyeth presented with phase I studies for thrombosis ongoing
Read More
Ipilimumab studied in second-line metastatic melanoma patients
Read More
Results of study comparing Emisphere's oral heparin to injectable heparin
Read More
Novel agents for metabolic disorders reported in recent patents
Read More
Myozyme approved for Pompe disease in Europe
Read More
Serono seeks U.S., European approvals for new Rebif formulation
Read More
New agents for endocrine-related disorders imparted in recent patent literature
Read More
European approval for Erbitux in head and neck cancer
Read More
AEterna Zentaris presents preclinical data on ZEN-017, a novel tubulin and topo II inhibitor
Read More
VX-001 vaccine well tolerated and effective in phase I study in advanced cancer patients
Read More
EC-0225: A folate-targeted chemotherapeutic conjugate from Endocyte
Read More
Preclinical data behind ENMD-1198's IND approval presented
Read More
